Joshua Reed
Director of Finance/CFO chez OMEGA THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Joshua Reed is an Independent Director at Scholar Rock Holding Corp.
and the Chief Financial & Accounting Officer at Omega Therapeutics, Inc. He was previously the Vice President & Head-Finance Operations at Bristol Myers Squibb Co. from 2016 to 2018, Vice President-Strategic Business Development at JPMorgan Chase & Co. from 2002 to 2005, and the Chief Financial Officer & Treasurer at Aldeyra Therapeutics, Inc. from 2018 to 2022.
Reed received his undergraduate degree from Rutgers State University of New Jersey and his MBA from Stephen M.
Ross School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Joshua Reed
| Sociétés | Poste | Début |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Director/Board Member | 18/03/2021 |
| OMEGA THERAPEUTICS, INC. | Director of Finance/CFO | 23/05/2022 |
Anciens postes connus de Joshua Reed
| Sociétés | Poste | Fin |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Director of Finance/CFO | 10/05/2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/07/2018 |
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01/01/2005 |
Formation de Joshua Reed
| Rutgers State University of New Jersey | Undergraduate Degree |
| Stephen M. Ross School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| JPMORGAN CHASE & CO. | Finance |
| ALDEYRA THERAPEUTICS, INC. | Health Technology |
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| OMEGA THERAPEUTICS, INC. | Health Technology |
